Sabinsa Corporation has announced the results of a recent study conducted by researchers at Vanderbilt University, which involved 120 subjects with an average selenium intake of 10 micrograms per day (well below the recommended 55mg per day) who were provided with selenium supplements in either the form of sodium selenite or selenomethionine (Selenium SeLECT®). The researchers found that less than half the amount of selenium as selenomethionine was needed to reach optimal levels compared to selenium as selenite, indicating that it is more bioavailable. This study has been accepted for publication in the American Journal of Clinical Nutrition.
Sabinsa SeleniumSeLECT® found more bioavailable than other forms of selenium -NPI Center's e-newsletter
